Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Psychiatry/Neuroscience

Early-onset Parkinson's Disease

EOPD is considered a complex disorder and is most likely associated with the effects of multiple genes in combination with environmental factors.
CME credit is no longer available for this conference.

Course Authors

Roy N. Alcalay, M.D., M.Sc., and Karen Marder, M.D., M.P.H.

Dr. Alcalay is Assistant Professor of Neurology, and Dr. Marder is Professor of Neurology (in the Sergievsky Center, Taub Institute and Psychiatry), Columbia University College of Physicians and Surgeons, New York.

Within the past 12 months, Dr. Alcalay reports no commercial conflicts of interest and Dr. Marder has received grant/research support from Neurogen.

Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.

Release Date: 06/28/2010

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Identify genetic risk factors for Early-onset Parkinson's disease (EOPD)

  • List the clinical characteristics of EOPD and apply them to the differential diagnosis of EOPD

  • Compare EOPD and late-onset PD

  • Discuss treatment options for EOPD.

 

TERMS AND CONDITIONS

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms.

Courses You Might Like

Emerging Research on the Use of Psychedelics in the Treatment of Mental Illness

In the last 30 years, revived interest in the application of psychedelic compounds in psychiatry has created a huge body of scientific knowledge on the pharmacological and therapeutic action of these compounds. these compounds.
Authors: Danilo De Gregorio, PharmD, Ph.D.
View Course
More

The Impact of COVID-19 on Mental Health

COVID-19 and the pandemic greatly affected mental health.
Authors: Roger Ho M.D., F.R.C.Psych., F.R.C.P.C., and Cyrus Ho M.B.B.S., M.R.C.Psych.
View Course
More

Molecular Mechanisms of Cognitive Deficits in Schizophrenia

Treatment of the cognitive symptoms of schizophrenia has been the focus of much research because they are highly predictive of long-term functional outcome.
Authors: Sarah Canetta, Ph.D., and Christoph Kellendonk, Ph.D.
View Course
More

PTSD: Current Therapies

Psychological trauma, defined as threat to life or integrity of yourself or someone close to you, affects over half of the U.S. population at some time in their lives.
Authors: J. Douglas Bremner, M.D.
View Course
More

Current and Emerging Therapies for Relapsing-Remitting Multiple Sclerosis

No other area of neurology has seen such a remarkable explosion of new drugs.
Authors: Aaron Miller, M.D..
View Course
More

Glial Cells

Glia are involved in nearly every aspect of brain function, including brain development, homeostasis, information processing, neurological disease and psychiatric illness.
Authors: R. Douglas Fields, Ph.D.
View Course
More